A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery

NCT04888975 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphedema
Lymphedema, Breast Cancer
Lymphedema Arm

Interventions

DEVICE: Dayspring Active Wearable Compression System

Sponsor

Koya Medical, Inc.